- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.03. | VITURA HEALTH LIMITED: S&P DJI Announces March 2025 Quarterly Rebalance | - | ASX | ||
| 04.03. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
| 28.02. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
| 28.02. | VITURA HEALTH LIMITED: Investor webinar and presentation | 2 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 24.02. | VITURA HEALTH LIMITED: Cleansing Notice | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| 24.02. | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | - | ASX | ||
| 24.02. | VITURA HEALTH LIMITED: Vitura completes acquisition of Canview platform | - | ASX | ||
| 24.02. | VITURA HEALTH LIMITED: H1 FY2025 financial results | - | ASX | ||
| 24.02. | VITURA HEALTH LIMITED: 2025 Half-Year Financial Report | - | ASX | ||
| 24.02. | VITURA HEALTH LIMITED: Appendix 4D | - | ASX | ||
| 20.02. | VITURA HEALTH LIMITED: Vitura completes acquisition of Candor Medical | 2 | ASX | ||
| 17.02. | VITURA HEALTH LIMITED: Update - Proposed issue of securities - VIT | - | ASX | ||
| 17.02. | VITURA HEALTH LIMITED: Becoming a substantial holder - updated | - | ASX | ||
| 14.02. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
| 13.02. | VITURA HEALTH LIMITED: Change of Substantial Holder - G Headley | 2 | ASX | ||
| 12.02. | XFRA 1CE0: WIEDERAUFNAHME/RESUMPTION | 88 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 12.02. | Health Check: Vitura Health swoops on medical dope telehealth platform | 1 | Stockhead | ||
| 11.02. | VITURA HEALTH LIMITED: Change of Substantial Holder - M Jansen | - | ASX | ||
| 11.02. | VITURA HEALTH LIMITED: Section 708A Cleansing Notice | - | ASX |
Seite:
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,950 | -3,80 % | Stocks in Play: Aurora Cannabis Inc. | ||
| TILRAY BRANDS | 0,569 | -5,42 % | Tilray Brands Inc: Tilray moves Good Supply Jean Guy cultivation to Quebec | ||
| ORGANIGRAM GLOBAL | 0,931 | -1,44 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 01.04.2025 | Das Instrument 0OG0 CA68620P7056 ORGANIGRAM HLDGS INC. EQUITY wird cum Kapitalmassnahme gehandelt am 01.04.2025 und ex Kapitalmassnahme am 02.04.2025 The instrument 0OG0 CA68620P7056 ORGANIGRAM HLDGS... ► Artikel lesen | |
| SNDL | 1,300 | -2,40 % | SNDL Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| MYDECINE INNOVATIONS GROUP | 0,002 | 0,00 % | Aquis Stock Exchange: Withdrawal from Trading - Mydecine Innovations Group Inc. | Aquis Stock Exchange
Aquis Stock Exchange: Withdrawal from Trading 02-Apr-2025 / 07:00 GMT/BST
The issuer is solely responsible for the content of this... ► Artikel lesen | |
| BIONANO GENOMICS | 3,330 | -11,67 % | Bionano Genomics: Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 | SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue outlook... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 15,260 | 0,00 % | Tonix Pharmaceuticals Holding: Tonix's Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year | CHATHAM, NJ / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial... ► Artikel lesen | |
| HIGH TIDE | 1,656 | -6,23 % | High Tide Inc.: High Tide Reports First Quarter 2025 Financial Results Featuring Record Revenue of $142.5 Million | Same store sales increased 5% year over year, representing the fastest pace of growth during the past four quarters
Cabana Club loyalty program exceeds 1.76 million... ► Artikel lesen | |
| JAGUAR HEALTH | 4,500 | -0,22 % | Jaguar Health, Inc.: Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules | SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / April 1, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced the closing of its previously announced private placement.Jaguar's... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 2,210 | -5,76 % | Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program | Reiterates Planned Cytisinicline NDA Submission Expected at the End of Q2 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, March 11, 2025 SEATTLE and VANCOUVER, British... ► Artikel lesen | |
| SEELOS THERAPEUTICS | 2,000 | 0,00 % | Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc. ... | NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A Ordinary Shares, unit, and warrant of Patria Latin American Opportunity Acquisition... ► Artikel lesen | |
| PLANTFUEL LIFE | 0,009 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.03.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 24.03.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.03.2025ISIN NameCA12571Q4034 CMC... ► Artikel lesen | |
| MEDIPHARM LABS | 0,065 | -1,21 % | MediPharm Labs Corp.: MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results | Annual Net Revenue Increase of 27% to $42M, Driven by Record $18M International Medical Cannabis Revenue and Approaching Positive Adjusted EBITDA(1) for Q4. TORONTO, March 31, 2025 /PRNewswire/... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,111 | +54,17 % | Argent BioPharma gains approval for prescription sales of CannEpil epilepsy treatment in Germany | ||
| AYR WELLNESS | 0,156 | -2,62 % | Ayr Wellness Inc.: AYR Wellness Reports Fourth Quarter and Full Year 2024 Results | MIAMI, March 06, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, is reporting financial... ► Artikel lesen |
Das Unternehmen VITURA HEALTH LIMITED kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,027 Euro und damit -3,64 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.
